Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Are Hedge Funds Right About This Stock?

Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a buy right now? Hedge funds are getting more bullish. The number of long hedge fund positions improved by 1 in recent months.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

In the financial world, there are many methods shareholders can use to analyze the equity markets. Some of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite investment managers can beat the S&P 500 by a solid margin (see just how much).

Just as important, optimistic insider trading sentiment is a second way to break down the financial markets. Obviously, there are lots of reasons for an executive to sell shares of his or her company, but only one, very simple reason why they would initiate a purchase. Many academic studies have demonstrated the useful potential of this strategy if investors understand what to do (learn more here).

Keeping this in mind, it’s important to take a look at the latest action surrounding Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Hedge fund activity in Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

At year’s end, a total of 17 of the hedge funds we track were bullish in this stock, a change of 6% from the third quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were increasing their holdings substantially.

According to our comprehensive database, Jérôme Pfund and Michael Sjöström’s Sectoral Asset Management had the largest position in Regeneron Pharmaceuticals Inc (NASDAQ:REGN), worth close to $59 million, accounting for 2.1% of its total 13F portfolio. Coming in second is Donald Chiboucis of Columbus Circle Investors, with a $54 million position; 0% of its 13F portfolio is allocated to the company. Some other hedgies that hold long positions include Christopher MedlockáJames’s Partner Fund Management, and Samuel Isaly’s OrbiMed Advisors.

As aggregate interest increased, specific money managers have been driving this bullishness. Renaissance Technologies, managed by Jim Simons, established the biggest position in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Renaissance Technologies had 16 million invested in the company at the end of the quarter. Phill Gross and Robert Atchinson’s Adage Capital Management also made a $9 million investment in the stock during the quarter. The other funds with new positions in the stock are Malcolm Fairbairn’s Ascend Capital, D. E. Shaw’s D E Shaw, and Ken Griffin’s Citadel Investment Group.

How are insiders trading Regeneron Pharmaceuticals Inc (NASDAQ:REGN)?

Insider buying is at its handiest when the primary stock in question has experienced transactions within the past half-year. Over the latest six-month time period, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has seen zero unique insiders buying, and 16 insider sales (see the details of insider trades here).

With the results exhibited by Insider Monkey’s research, everyday investors should always watch hedge fund and insider trading activity, and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Best States To Practice Medicine

The 10 Best States to Have a Business

The 12 Most Expensive Apple (AAPL) Apps in the Market

The 10 Richest Billionaires in the World

10 Biggest Kickstarter Failures

The 10 Best Places to Work At

The Top 10 of Google Inc (GOOGL)’s Most Expensive Acquisitions

13 Best Cities to Visit in South America

10 Most Expensive Works of Art of All Time

The 10 Richest Banks in the World

The 10 Best-Paying Jobs in America (2014)

7 Most Expensive Foods in the World

The World’s Top 10 Earning Authors

Five Wicked and Very Expensive Items (and Other “Stuff”) Sold on eBay

10 Biggest Celebrity Bankruptcies

The Top 10 Highest Paid CEOs in 2014

The 10 Most Expensive Real Estate Cities in America

10 Most Expensive States To Live In America

The 10 Best Airlines in the World

The 10 Best-Selling Cars in 2014

The 10 Best Industries to Invest In

The 10 Most Expensive States to Own a Car In

Top 10 Business Schools in US: 2014 Rankings

Top 20 Female Billionaires in 2014

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!